Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
· 9/15/2026, 3:08:48 PM· 2 min read
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
Read original story →Related stories
business
U.S. FDA issues observation to Aurobindo Pharma arm’s API unit
business
August retail inflation raises chances of RBI rate hike in October, say economists
business
FPIs in selling spree, offload 44% of August inflows in 10 days
business